| |
|
|
|
Aridis Pharmaceuticals Inc  
|
|
7.05 -0.14 (-0.02%) |
08-05 16:00 |
|
Open: |
6.9222 |
Pre close: |
7.19 |
Target:
|
8.97
|
|
High: |
7.32 |
Low: |
6.9222 |
Resistance:
|
7.68
8.65
|
|
Volume: |
3,975 |
Market Cap: |
63M |
Support:
|
6.10
5.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.04
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
6.97 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
6.67 |
Stochastic Oscillator |
%K(14,3):
|
42.09 |
|
MA(250): |
6.63  |
%D(3): |
37.07 |
|
Average Volume(K) |
3-Month: |
1063
|
52-Week |
High:
|
12.40 |
|
10-Days: |
697 |
Low: |
3.80 |
|
RSI |
RSI(14):
|
51.93 |
Change(%): |
-16.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.250 |
Return on Equity (ttm) |
-344.4 |
Shares Out. (M) |
8.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-77.1 |
Shares Float (M) |
5.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.77 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.10 |
|
Forward EPS |
-3.510 |
Gross Profit (p.s.) |
-2.585 |
Shares Short (K) |
28 |
|
Book Value (p.s.) |
-0.270 |
EBITDA (p.s.) |
-3.091 |
P/E |
-2.17 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-26.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.92 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.32 |
P/CF |
-12.78 |
|
|
|
|
|
|
